Iraq, Sanofi partner to boost healthcare
Iraq's Ministry of Health signed a memorandum of understanding with French pharmaceutical company Sanofi on Sunday to expand medical training, combat counterfeit medicines, and modernize the country's healthcare system.
Speaking at a forum on biosimilar medicines and intellectual property, Deputy Health Minister Hani Al-Oqabi framed the agreement as part of a broader strategy to engage global health institutions and apply international expertise in Iraq.
'The deal goes beyond pharmaceuticals,' he noted. 'It includes workforce development, nursing programs, and coordinated efforts to counter the spread of fake medicines.'
Al-Oqabi highlighted Prime Minister Mohammed Shia Al-Sudani's push to attract foreign investment, particularly in pharmaceuticals, crediting the national program with recent advances in facility upgrades and workforce expansion.
Rami Nassar, Head of Sanofi's Near East Pharmaceutical Unit and Director of its Jordan office, drew attention to the company's integration of artificial intelligence in research and development, with a focus on improving patient outcomes.
He also outlined the 'Imkan' initiative, launched in Iraq in February, which introduced a structured approach to health system support—from training on health technology assessment to sharing case studies from nearby countries.
'We've completed two phases of the agreement and will begin the third in September, focusing on training for nurses and allied health professionals,' Nassar confirmed, adding that the final stage, planned for the end of the year, will center on health economics.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Iraq Business
18 hours ago
- Iraq Business
Sanofi Discusses Collaboration on Biotech and Pharma in Iraq
By John Lee. The Iraqi Ministry of Health has held high-level discussions with a delegation from French pharmaceutical company Sanofi, aimed at strengthening collaboration on biopharmaceutical development, healthcare capacity-building, and policy modernisation. The meeting was chaired by Health Minister Dr. Saleh Mahdi Al-Hasnawi, who welcomed Sanofi's delegation led by Dr. Rami Nassar. The minister emphasised the importance of international partnerships in supporting Iraq's health sector, affirming the ministry's commitment to aligning pharmaceutical policy with global standards. As part of the ongoing collaboration, the two sides discussed the enhancement of the "Imkan" programme, a joint initiative to improve Iraq's healthcare delivery and provide advanced training for medical personnel. Separately, the Ministry's Directorate of Specialised Centres held a three-day scientific workshop titled "Biosimilars and Intellectual Property: Shaping Future Policy Based on Regional Experiences," under the "Imkan" programme and in partnership with Sanofi. The workshop explored regulatory frameworks for biosimilars, intellectual property rights, and evidence-based pharmaceutical policies. Speaking on behalf of the minister, Technical Deputy Dr. Hani Al-Aqabi reiterated Iraq's intention to build strategic partnerships with global healthcare leaders. He highlighted the importance of updating Iraq's pharmaceutical regulations while protecting intellectual property and supporting local industry in line with government directives. Dr. Ahmed Abbadi, Director of Specialised Centres, described the workshop as a vital platform for exchanging expertise. Participants included representatives from the Jordanian Food and Drug Administration, the Lebanese Ministry of Health, and various senior Iraqi health officials. The event concluded with a recognition ceremony, awarding the "Imkan Shield" to key contributors from the ministry and Sanofi, reflecting their role in strengthening Iraq's healthcare infrastructure. (Source: Ministry of Health)
Shafaq News
a day ago
- Shafaq News
Iraq grants patents for cancer therapy and smart tech innovations
Shafaq News – Baghdad Iraq's Directorate of Patents and Industrial Designs has granted four new patents for scientific innovations in cancer treatment, sustainable architecture, soil monitoring, and water management, the Central Organization for Standardization and Quality Control announced on Monday. In a statement, the directorate detailed the awarded patents, including a gold-based compound derived from sulfadiazine for breast cancer treatment, developed by researchers at the University of Kufa. The compound has demonstrated promising results in inhibiting cancer cell growth. Also recognized was the "Heliodon Device" from the University of Technology, which is designed to analyze the impact of sunlight on architectural structures, providing data to optimize building designs for environmental efficiency. A third patent was issued for the "Dual Automatic Lysimeter-Hygrometer," a smart system capable of measuring key soil and water properties to aid agricultural planning and land evaluation. The fourth innovation, the "Wireless Float Valve," aims to improve the efficiency of water pumping systems, particularly in areas with limited access to automated infrastructure. The head of the Central Organization for Standardization and Quality Control, Fayadh Mohammed Abd, praised the achievements, stating that they 'reflect the growing capacity of Iraqi researchers and mark a significant step forward in the country's scientific development.' Mohammed Jamal Jassim, Director of the Patents and Industrial Designs Directorate, noted that all the awarded innovations underwent rigorous evaluation per international standards.
Shafaq News
a day ago
- Shafaq News
Gaza famine toll reaches 147
Shafaq News – Gaza Gaza hospitals recorded 14 new starvation-related deaths in the past 24 hours, raising the total to 147, including 88 children, according to the Health Ministry on Monday. The Gaza Government Media Office warned that over 40,000 infants are at risk of fatal hunger as Israel maintains a five-month blockade on baby formula shipments. Labeling the crisis a 'silent genocide,' the office demanded the immediate and unconditional opening of border crossings to allow critical humanitarian supplies. The statement also highlighted that infants under one are facing 'slow death' due to a total ban on formula, placing full blame on Israel, its allies, and international bodies for failing to intervene. Human rights groups condemned recent food airdrops as both inadequate and degrading, with Euro-Med Monitor calling them 'an act of humiliation' and accusing Israel of weaponizing hunger through blockades and attacks near aid sites. The Palestinian Centre for Human Rights (PCHR) dismissed the airdrops as a 'false humanitarian cover,' arguing they violate International Court of Justice rulings that require safe, unobstructed aid delivery. PCHR Director Raji Sourani denounced the effort, saying it 'wastes the humanity of starving Palestinians' while citing over 1,100 deaths and thousands of injuries during chaotic aid scrambles since May. With 2.3 million Palestinians displaced into less than 15% of the #Gaza Strip due to Israeli control and forced evacuation orders, airdropped aid poses a serious risk to civilian lives amid severe overcrowding and the absence of safe areas #GazaStarving — Euro-Med Monitor (@EuroMedHR) July 28, 2025 These developments unfold as British Prime Minister Keir Starmer prepares to press US President Donald Trump on the crisis, with The Times reporting Starmer is 'horrified' by the images of famine and plans to push for a ceasefire and recognition of Palestinian statehood. Trump confirmed Gaza will be a central topic during their upcoming talks, noting the UK's active role in current diplomatic efforts.
